Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle

This article was originally published in The Tan Sheet

Executive Summary

FDA's final rule for dietary supplement good manufacturing practices completed its phase-in for the industry June 25, and the agency now prepares to conduct inspections of small firms, which have struggled the most to comply with the regulation

Related Content

GMP Qualification And Testing Provisions Still Trip Supplement Firms
Supplement Firms Should Work Toward Sharing GMP Audits – FDA's Williams
Timely 483 Response Can Ease Agency Enforcement Action – FDA Official
FDA Publishes Small Entity Guide For Supplement GMPs
BI Nutraceuticals Extends Ingredient Sourcing Reach To Build Customer Base
SIDI Group Expects "Passport" To Business Growth With Standardized CofA
First GMP Warning Letter Reflects FDA's List Of Major Concerns
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
Atlas widens ED supplement recall
Looming GMPs Could Doom Some Firms Unless Industry, FDA Lend Support





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts